Bin Zhu

Dr. Bin Zhu

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2013 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
BZBin Zhu
Bin Zhu
YXYilan Xu
Yilan Xu
XLXiaoguang Liu
Xiaoguang Liu
ZLZhongjun Liu
Zhongjun Liu
GDGengting Dang
Gengting Dang

21 February 2024 in ACS Omega
Verified
Journal Article
Open access
YLYu Liu
Yu Liu
LWLinbang Wang
Linbang Wang
XDXinyu Dou
Xinyu Dou
MDMingze Du
Mingze Du
SMShuyuan Min
Shuyuan Min
XLXiaoguang Liu
Xiaoguang Liu
Zinc (Zn) is a bioabsorbable metal that shows great potential as an implant material for orthopedic applications. Suitable concentrations of zinc ions promote osteogenesis, while excess zinc ions cause apoptosis. As a result, the conflicting impacts of Zn2+ concentration on osteogenesis could prove to be significant problems for the creation of novel materials. This study thoroughly examined the cell viability, proliferation, and osteogenic differentiation of rat bone marrow mesenchymal stem cells (rBMSCs) cultured in various concentrations of Zn2+ in vitro and validated the osteogenesis effects of zinc implantation in vivo. The effective promotion of cell survival, proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cell (BMSCs) may be achieved at a low concentration of Zn2+ (125 μM). The excessively high concentration of zinc ions (>250 μM) not only reduces BMSCs’ viability and proliferation but also causes them to suffer apoptosis due to the disturbed zinc homeostasis and excessive Zn2+. Moreover, transcriptome sequencing was used to examine the underlying mechanisms of zinc-induced osteogenic differentiation with particular attention paid to the PI3K-AKT and TGF-β pathways. The present investigation elucidated the dual impacts of Zn2+ microenvironments on the osteogenic characteristics of rBMSCs and the associated processes and might offer significant insights for refining the blueprint for zinc-based biomaterials.

29 June 2022 in Molecular Genetics and Genomics
Verified
Journal Article
Open access
PDF file
BHBao Hai
Bao Hai
QSQingpeng Song
Qingpeng Song
CDChuanchao Du
Chuanchao Du
TMTianli Mao
Tianli Mao
FJFei Jia
Fei Jia
XLXiaoguang Liu
Xiaoguang Liu
We sought to identify novel biomarkers and related mechanisms that might shape the immune infiltration in IDD, thereby providing novel perspective for IDD diagnosis and therapies. Gene expression data sets GSE124272 (for initial analysis) and GSE56081 (for validation analysis) involving samples from IDD patients and healthy controls were retrieved from the Gene Expression Omnibus (GEO) database. Immune genes associated with IDD were identified by GSEA; module genes that exhibited coordinated expression patterns and the strongest positive or negative correlation with IDD were identified by WGCNA. The intersection between immune genes and module genes was used for LASSO variable selection, whereby we obtained pivotal genes that were highly representative of IDD. We then correlated (Pearson correlation) the expression of pivotal genes with immune cell proportion inferred by CIBERSORT algorithm, and revealed the potential immune-regulatory roles of pivotal genes on the pathogenesis of IDD. We discovered several immune-associated pathways in which IDD-associated immune genes were highly clustered, and identified two gene modules that might promote or inhibit the pathogenesis of IDD. These candidate genes were further narrowed down to 8 pivotal genes, namely, MSH2, LY96, ADAM8, HEBP2, ANXA3, RAB24, ZBTB16 and PIK3CD, among which ANXA3, MSH2, ZBTB16, LY96, PIK3CD, ZBTB16, and ADAM8 were revealed to be correlated with the proportion of CD8 T cells and resting memory CD4 T cells. This work identified 8 pivotal genes that might be involved in the pathogenesis of IDD through triggering various immune-associated pathways and altering the composition of immune and myeloid cells in IDD patients, which provides novel perspectives on IDD diagnosis and treatment.

14 December 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
CHChengfang Hu
Chengfang Hu
BZBin Zhu
Bin Zhu
YWYanmao Wang
Yanmao Wang
FYFei Yang
Fei Yang
JZJun Zhang
Jun Zhang
CLCongfeng Luo
Congfeng Luo
To compare the reliability and effectiveness of blood blow restriction resistance training (BFR) versus traditional weight-bearing training (WB) in knee osteoarthritis (KOA) patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Methods: This multicenter randomized controlled trial was conducted from January 2021 to June 2022 at Shanghai Jiao Tong University affiliated Sixth People’s Hospital and The People’s Hospital of Mengla County. A total of 120 outpatients were recruited and randomized to perform WB (n=60) or BFR (n=60) resistance training protocols in accordance with standard recommended protocols for 12 weeks. Demographic data and Kellgren and Lawrence grading system scores were collected. Pain, range of motion (ROM), scaled maximal isotonic strength (10RM), self-reported function (KOOS), and 30-s chair sit-to-stand test results were assessed at weeks 1, 4, and 12.Results: 112 patients (57 in the WB group, 55 in the BFR group) completed the training programs and assessments. No significant intergroup demographic differences were noted. ROM and scaled 10RM significantly increased at the 4- and 12-week assessments and differed significantly between groups. The pain, ability of daily living and quality of life subscale in KOOS increased significantly at the 12-week assessment and differed significantly between groups, adjusted for baseline value. Significant and comparable increases in 30-s chair sit-to-stand test results were observed within and between study groups.Conclusion: BFR training enhanced muscle strength, reduced pain, and improved daily living and sports activities in patients with KOA, compared to WB training alone. BFR should be recommended for rehabilitation in KOA individuals with MASLD.Clinical trial registration number: ChiCTR2100042872.

1 May 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
BHBao Hai
Bao Hai
XPXiaoyu Pan
Xiaoyu Pan
CDChuanchao Du
Chuanchao Du
TMTianli Mao
Tianli Mao
FJFei Jia
Fei Jia
BZBin Zhu
Bin Zhu
Introduction: Chordoma is a malignant primary bone tumor that is found in the spine and skull. X-inactive specific transcript (XIST) is a long non-coding RNA (lncRNA) is known to be involved in the development of various cancers, but its precise function and mechanism in human chordoma have not been elucidated. Here, we investigated the role of lncRNA XIST in chordoma progression. Methods: Quantitative real time-polymerase chain reaction (qRT-PCR) was performed to determine lncRNA XIST expression in human chordoma tissues and matched-noncancerous tissues. Western blot was used to determine protein expression. Silencing and overexpression of lncRNA XIST were carried out by RNA interference (RNAi) and lentiviral transduction, respectively. Cell Counting Kit-8 (CCK-8) assay and flow cytometry were employed to examine the effects of lncRNA XIST on growth of human chordoma cells. Lastly, the role of lncRNA XIST in vivo was explored using a xenograft model. Results: We found that lncRNA XIST expression was upregulated in chordoma and strongly correlated with poor patient prognosis. Moreover, lncRNA XIST promoted proliferation and inhibited apoptosis of chordoma cells. Mechanistically, upregulation of lncRNA XIST led to a decrease in miR-124-3p expression, thereby promoting the expression of the miR-124-3p target gene, inhibitor of apoptosis-stimulating protein of p53 (iASPP). Addition of miR-124-3p inhibitor or mimic reversed the effects induced by lncRNA XIST silencing or overexpression on chordoma cell proliferation. Lastly, using a xenograft mouse model, we found that silencing of lncRNA XIST decreased tumorigenicity in vivo, as shown by increased tumor cell apoptosis. Conclusion: Our findings demonstrate a key role for lncRNA XIST in chordoma progression by regulating miR124-3p/iAPSS pathway.

18 May 2016 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
SLShanshan Liu
Shanshan Liu
QZQi Zhang
Qi Zhang
CYChengying Yin
Chengying Yin
SLSong Liu
Song Liu
QCQueenie Chan
Queenie Chan
BZBin Zhu
Bin Zhu
Purpose To determine the optimal slice thickness, playback rate, and scan time for uterine peristalsis with 3.0T magnetic resonance imaging (MRI). Materials and Methods In all, 23 young female volunteers underwent a 3.0T MRI scan with different slice thicknesses of 3 mm (Cine3mm), 5 mm (Cine5mm), and 7 mm (Cine7mm) for 6 minutes. Subjective image quality score, signal‐to‐noise ratios (SNRs), and contrast‐to‐noise ratios (CNRs) of those MR images were evaluated by two radiologists independently. The number, intensity, and direction of uterine peristalsis with different thickness were compared at various playback rates. Also, the peristalsis frequency was counted and compared in different acquisition durations (1–6 minutes). Results The subjective image quality score, peristalsis number, and intensity were significantly higher in Cine7mm and Cine5mm than Cine3mm (P < 0.05), while the SNRs and CNRs of Cine7mm were significantly higher than Cine3mm (P < 0.05). Peristalsis numbers did not differ significantly at different playback rates with the same slice thickness (P = 0.548–0.962). However, peristalsis intensity at 12×, and 15× was significantly greater than that at 8× the actual speed for Cine7mm and Cine5mm (P < 0.05). The peristalsis frequency at 3, 4, 5, 6 minutes was significantly higher than that at 1 minute and 2 minutes (P < 0.05). Conclusion We recommend a slice thickness of 5 mm or 7 mm and a scan time of 3 minutes for uterine peristalsis with 3.0T MRI, and a playback rate of 12× or 15× the actual speed for peristalsis observation. J. Magn. Reson. Imaging 2016;44:1397–1404.